Pharmacokinetics of oxaliplatin during chronomodulated infusion in metastatic gastrointestinal cancer patients: A pilot investigation with preliminary results
- 31 December 2003
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 54 (5-6) , 475-479
- https://doi.org/10.1078/0940-2993-00283
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Interindividual differences in oxaliplatin pharmacokinetics.Int. Journal of Clinical Pharmacology and Therapeutics, 2002
- Biweekly Chemotherapy With Oxaliplatin, Irinotecan, Infusional Fluorouracil, and Leucovorin: A Pilot Study in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2002
- Coordination of circadian timing in mammalsNature, 2002
- Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patientsCancer Chemotherapy and Pharmacology, 2002
- Tumor-based rhythms of anticancer efficacy in experimental modelsChronobiology International, 2002
- Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal functionCancer Chemotherapy and Pharmacology, 2000
- OxaliplatinClinical Pharmacokinetics, 2000
- Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancerPublished by Elsevier ,1997
- Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional TrialJNCI Journal of the National Cancer Institute, 1994
- Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancerClinical Pharmacology & Therapeutics, 1994